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Abstract
Objectives While magnetic resonance imaging (MRI) is con-
sidered a helpful diagnostic tool in breast imaging, discussions
are ongoing about appropriate protocols and indications. The
European Society of Breast Imaging (EUSOBI) launched a sur-
vey to evaluate the utilisation of breast MRI in clinical practice.
Methods An online survey reviewed by the EUSOBI board
and committees was distributed amongst members. The ques-
tions encompassed: training and experience; annual breast
MRI and MRI-guided-intervention workload; examination
protocols; indications; reporting habits and preferences. Data
were summarised and subgroups compared using χ2 test.
Results Of 647 EUSOBI members, 177 (27.4%) answered the
survey. The majority were radiologists (90.5%), half of them
based in academic centres (51.9%). Common indications for
MRI included cancer staging, treatment monitoring, high-risk
screening and problem-solving, and differed significantly be-
tween countries (p≤0.03). Structured reporting and BI-RADS
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were mostly used. Breast radiologists with ≤10 years of expe-
rience preferred inclusion of additional techniques, such as
T2/STIR (p=0.03) and DWI (p=0.08) in the scan protocol.
MRI-guided interventions were performed by a minority of
participants (35.4%).
Conclusions The utilisation of breast MRI in clinical practice
is generally in line with international recommendations. There
are substantial differences between countries. MRI-guided in-
terventions and functional MRI parameters are not widely
available.
Key points
• MRI is commonly used for the detection and characterisa-
tion of breast lesions.
•Clinical practice standards are generally in line with current
recommendations.
• Standardised criteria and diagnostic categories (mainly BI-
RADS) are widely adopted.
• Younger radiologists value additional techniques, such as
T2/STIR and DWI.
• MRI-guided breast biopsy is not widely available.
Keywords Breast .Magnetic resonance imaging .Surveyand
Questionnaires . Practice Guideline . Radiologists
Introduction
Magnetic resonance imaging (MRI) is widely used for the
detection and characterisation of breast lesions [1]. Due to
many reasons, including the relatively high cost and its limited
availability, MRI is utilised mainly for selected indications
such as screening modality in high-risk women, preoperative
evaluation of disease extent of specific breast cancer subtypes,
assessment of response to neoadjuvant therapy [2–6].
However, indications vary due to clinical preferences, official
recommendations [2, 7, 8], as well as local health care system
reimbursement policies, which do change over time as the
body of evidence evolves [9–12].
Another issue contributing to inter-institutional and inter-
national variations in the use of breast MRI are uncertainties
regarding image acquisition and interpretation. While there is
consensus about the fact that contrast-enhanced sequences are
mandatory in breast MRI, the usage and value of additional
techniques or specific reading protocols and criteria remain a
matter of debate. Furthermore, the on-going debate about the
impact of preoperative MRI regarding surgical outcomes
stresses the importance of MRI-guided interventions for diag-
nosis and treatment planning.
In this context, the European Society of Breast Imaging
(EUSOBI) decided to launch a survey among its members to
gather representative data on how breastMRI is currently used
in clinical practice. The results of this survey are reported in
this paper.
Materials and methods
Survey design and distribution
Two board certified radiologists, one with more than 10 years
of experience in breast imaging and breastMRI and one with a
background in survey methodology, developed the survey.
The questions encompassed: training and experience; annual
breast MRI and MRI-guided intervention workload; indica-
tions and technical details of the MRI examination; and
reporting habits and preferences. The full questionnaire is
available online (https://de.surveymonkey.com/r/RRPQHNJ?
sm=xQclpzxR8w3M4Q%2btaA9q2A%3d%3d). Once the
survey was reviewed and approved by members of the
EUSOBI executive board and committees the survey was
published online, using a dedicated software platform
(SurveyMonkey, Palo Alto, CA). EUSOBI members were
invited to participate by an email that contained a link to the
survey, which was sent out from the central EUSOBI office.
The survey was available online for six weeks, and two
reminders were sent out during this period, by email and on
the EUSOBI Facebook page (https://www.facebook.com/
eusobieuropeansociety/?ref=aymt_homepage_panel).
Data analysis
After the survey was closed, spreadsheet data were exported
for statistical analysis. Responses to the questions were ex-
tracted and summarised. Based on this first data evaluation,
data were separated into groups, considering different types of
institutions (academic, community, private), and different
geographical areas (e.g. southern Europe vs. northern
Europe as defined in Figure 1). The separation in different
geographical areas was obtained by evaluating clustered data.
Thus, the countries of participants that returned similar an-
swers were considered together. The responses between the
subgroups were compared using the χ2 test. Statistical analy-
sis was performed using SPSS v.20 for Windows (IBM,
Armonk, New York, USA).
Data were reported as frequencies and percentages.
Shapiro-Wilk test was used to test for normal distribution.
Mean and standard deviation (SD) were used in the case of
normal or near-normal distribution, median and interquartile
range (IQR) in the case of non-normal distribution.
Results
A total of 189 survey participants were noted. Of these, 177
confirmed that they were EUSOBI members, yielding a re-
sponse rate among members of 27.4% (Figure 1).
More than half the participants were based at an academic
centre (51.9%) (Figure 2a). Board-certified radiologists,
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primarily, responded to the survey (90.5%) (Figure 2b).
Further details are given in Table 1.
Indications for breast MRI
The most common indication was preoperative MRI in wom-
en with breast cancer (Table 2, Figure 3), followed by evalu-
ation of breast implants (Table 2, Figure 4).
Evaluation of implants was mainly performed in patients
with symptoms and inconclusive findings on conventional
imaging (114/165, 69.1%). Screening in the absence of a clin-
ical complaint was rarely performed (9.7%).
Monitoring of neoadjuvant therapy with breast MRI was
more frequently performed in academic centres (92.1% com-
pared to 78.3% in community hospitals and 70% in private
hospitals, p=0.006). The difference between academic and
non-academic centres was particularly evident when the eval-
uation of early response was considered, which was signifi-
cantly more common in academic centres (84.3%, 67.4%, and
48.4% respectively, p=0.001).
Breast MRI, in patients with nipple discharge was per-
formed mainly in cases with inconclusive findings on conven-
tional imaging (101 of 166 answers, 60.8%), while only 6.6%
always performed MRI in women with nipple discharge.
Geographical areas and their influence on indications
for MRI
Indications varied between geographical regions. In southern
countries (as defined in Figure 1), preoperative breast MRI
was more often performed in all cancer patients rather than
only for invasive lobular carcinoma (32.1%, compared to 6%
Fig. 1 Countries where the
participants were working at the
time of the survey (3/189 did not
answer, 1.6%). Four different
geographical areas were
distinguished: southern; northern
and eastern European countries;
and non-European countries.
Southern and northern countries
were considered together as
western European countries.
Other: countries of various
geographical areas in which only
one person answered the survey.
Footnotes: The number of
responders is indicated in the
horizontal -axis
Fig. 2 Clinical setting (a) and current position (b) of the people who participated in the survey
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in northern countries, p<0.001), and in patients with ductal
carcinoma in situ (50.9%, compared to 22.2% in northern
countries, p=0.003), or lesions with uncertain malignant po-
tential (32.1% compared to 11.1%, p=0.007) (Figure 3).
In northern countries, several other indications were less
frequently encountered: carcinoma of unknown primary
(80.9% of the cases compared to ≥ 88.5% in the other areas,
p=0.030); positive margins after breast-conserving surgery
(25.8% compared to ≥ 50% in the other areas, p=0.010);
personalised screening (25.0% compared to ≥ 46.1%,
p=0.007); inflammatory conditions (22.2% compared to ≥
46.1%, p=0.008); and nipple discharge (45.3% compared to
≥ 80.8%, p<0.001) (Figure 4).
Screening in high-risk women and evaluation of response
during neoadjuvant therapy were less frequently used in east-
ern countries (Figure 1) compared to western (northern and
southern countries in Figure 1) and non-EU countries (65.4%
compared to ≥ 83.3%, p=0.036, and 61.5% compared to
87.3%, p=0.010, respectively).
Reporting habits, diagnostic features, and MRI protocol
preferences
Morphology was considered to provide the most relevant di-
agnostic information (Table 3). Opinions differed significantly
when considering readers’ experience. Readers with more
than 10 years of experience in breast imaging found the infor-
mation of enhancement curves more important than did less-
experienced readers (p=0.042). However, readers with less
than 10 years of experience in breast imaging and breast
MRI tended to prefer multiparametric assessment and gave
higher usefulness scores for STIR/T2-weighted imaging
(p=0.030), DWI (p=0.080), and MRS (p=0.117) as compared
with radiologists with more years of experience. The value of
morphology was considered high according to both groups
(p>0.566).
Most participants utilised the general Picture Archiving
and Communication System (PACS) viewer and/or a dedicat-
ed MRI workstation as well as a standardised setup for
reporting (Table 4). No differences were found between the
different settings (p>0.238), nor when considering the
experience in breast imaging and breast MRI (≤ 10 years ver-
sus > 10 years, p>0.122).
The American College of Radiology Breast Imaging
Reporting and Data System (BI-RADS) [13] was used for
description and rating of the examination in the majority of
the cases, alone or in combination with further criteria or rat-
ing systems (Table 4). Structured reporting was widely used,
usually combined with free-text (Table 4).
Reporting preferences did not show significant differences
related to the clinical setting (p>0.137) or to experience
(p>0.168).
Answers regarding the technical protocols for breast MRI
are provided In Table 5. A dedicated breast coil with at least
four channels, and an automated injector for contrast medium
application were used by almost all responders. While the
majority of responders preferred three-dimensional (3D)
gradient-echo sequences for dynamic, contrast-enhanced
MRI, two-dimensional (2D) gradient-echo sequences were
used by almost one-fourth of the survey participants. Fat sat-
uration was favoured over non-fat-saturated sequences for
both T1- and T2-weighting (77% used fat-saturated T1-
weighted sequences alone and 71.4% used fat-saturated T2-
weighted sequences alone, or along with non-fat-saturated
Table 1 Years of experience in breast imaging and breast MRI of the
participants and number of examinations per year performed by the
centres
Range Median; IQR
Experience in breast imaging 0 - 40 12; 14
Experience in breast MRI 0 - 25 6; 8
Breast MRI/year 10 - 4000 200; 300
MR-guided interventions/year 2 - 350 20; 60
IQR: Interquartile range
Table 2 Indications for which breast MRI was used by the responders
Indications Positive answers %
(Yes/Total)*
Pre-operative MRI 100 (162/162)
ILC 75.9 (123/162)
Inconclusive findings 70.9 (115/162)
Dense breasts 58.0 (94/162)
DCIS 40.7 (66/162)
B3 25.9 (42/162)
Pre-menopause 22.8 (37/162)
All Cancers 15.7 (27/162)
APBI 7.4 (12/162)
Breast implants 99.4 (164/165)
CUP syndrome 89.6 (147/164)
Neoadjuvant Chemotherapy 84.2 (139/165)
Inconclusive findings 83.9 (117/141)
Screening in high-risk 83.9 (136/162)
Nipple discharge 67.3 (111/165)
BCS with positive margins 48.4 (78/161)
Screening after BCS 45.3 (73/161)
Personalised screening 40.5 (66/163)
Inflammatory conditions 38.6 (63/163)
*Percentages are calculated considering only positive (yes) or negative
(no) answers. When a question was not answered or the answer was BI
don’t know ,^ the answer was excluded from the calculation
ILC: invasive lobular cancer; DCIS: ductal carcinoma in situ; APBI:
accelerated partial breast irradiation; CUP: carcinoma of unknown prima-
ry; BCS: breast conserving surgery
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sequences). A large fraction (60%) of the survey participants
did acquire DWI regularly. Only a small number of partici-
pants (2%) made regular use of MRS.
Breast interventions
Only a minority of the participants (35.4%) used MR-guided
interventions, either wire-localisations or needle biopsies. Of
these 67 radiologists, 29 performed both biopsies and wire
localisations (43.3%), three used wire localisation exclusively
(4.5%), and 35 used biopsies exclusively (52.2%). The use of
planning software was more common than manual planning
(27 vs 17, 40.3% vs 25.4%), and sometimes both were used
together (14.9%).
MRI interventions, both wire localisation and biopsy, were
more often performed in an academic environment (p<0.004).
Discussion
The utilisation of breastMRI in clinical practice is generally in
line with international recommendations. There are substantial
differences between countries, regarding setting and reader
experience. MRI-guided interventions and functional MRI pa-
rameters are not widely available.
Indications for breast MRI
The survey responders actual use of breast MRI in different
clinical situations agrees with the current guidelines and state-
ments from various societies [2, 3, 7]. However, substantial
differences between different settings and countries were ob-
served: in southern countries, preoperative breast MRI is less
limited to specific breast cancer patient groups. This seems to
reflect the indications of current American practice parameters
[3], which suggest the use of MRI to define lesion extent and
muscle involvement, regardless of the histology, or to screen
for undetected contralateral cancers, although this subject is
still under debate [6]. Differences in clinical practice are also
likely related to the acceptance of preoperative MRI by other
specialists on the multidisciplinary team, particularly surgeons.
The assessment of response during or after neoadjuvant
therapy was more commonly performed in academic centres:
one may assume that a greater number of women are treated
Fig. 3 Indications for pre-operative breast MRI in different clinical
settings (a) and geographical areas (b). Footnotes: Pre-OP: pre-operative
MRI; ILC: invasive lobular carcinoma; APBI: accelerated partial breast
irradiation; DCIS: ductal carcinoma in situ; B3: high-risk lesions/lesions
with uncertain malignant potential
Fig. 4 Common indications for breast MRI in the different clinical settings. Footnotes: CUP: carcinoma of unknown primary; NAC: neoadjuvant
chemotherapy; BCS: breast-conserving surgery
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with neoadjuvant therapy in institutions involved in clinical
trials.
The evaluation of the response to treatment and screening
of high-risk women are less frequent indications in eastern
countries. This latter might reflect the current lack of
organised high-risk screening programs but both may also
be connected to cost-issues in situations where potential clin-
ical effects are not immediately perceived [14, 15].
While problem-solving as an indication for breast MRI is
still controversial according to the literature [2, 3], our results
show that breast MRI is commonly performed in patients with
inconclusive findings. This was true regardless of the setting
and/or the geographical area. The term ‘problem-solving’ is
used for largely different clinical situations, thus creating a
wide heterogeneity in the available data and evidence. This
might, at least partially, explain the divergence between guide-
lines and clinical practice [10, 16].
Further differences between southern and northern coun-
tries regarded indications such as evaluation of lesions of un-
certain malignant potential (B3), nipple discharge, inflamma-
tion, personalised screening, and evaluation after breast-
conserving surgery. Northern countries seem to guide their
practice more strictly in line with the available evidence that
is still limited regarding specific indications [17–22].
Breast MRI was only performed by a minority of survey
participants to check for implant rupture in asymptomatic
women. In the United States, MRI has been suggested as a
screening modality for implant rupture in asymptomatic wom-
en [23], but there is currently no evidence of its positive im-
pact on patient treatment and outcomes.
Reporting habits, diagnostic criteria and examination
protocols
The interpretation of breast MRI is a challenging task due to
the abundance of diagnostic criteria. Most participants of this
survey considered morphology the most important feature
when evaluating a lesion, along with the signal intensity time
curve type and the lesion appearance on T2-weighted se-
quences. We found that younger generations of breast radiol-
ogists gave more importance to multiparametric breast MRI,
including T2-weighted as well as DWI. This indicates a per-
sonal choice of young generations, who prefer to report breast
MRI looking at all available multiparametric data and do not
focus solely on dynamic post-contrast images. Several studies
already proved the usefulness of these approach [24, 25]. In
the last years, many centres – in particular academic centres -
introduced in their protocols both fat-suppressed and non fat-
suppressed T2 as well as DWI. Thus, younger generations are
more used to working with this kind of images. Whether our
results are related to a paradigm shift towards multiparametric
imaging or simply reflect personal preferences with the more
familiar technique was not investigated. In line with published
recommendations, most survey responders preferred a
standardised setting for image evaluation and reporting. For
Table 3 Responders’ opinion on
the impact of diagnostic criteria Diagnostic Value Enhancement Curves Morphology T2w
sequences
DWI MRS
High 57 (41.3) 125 (91.2) 46 (34.8) 36 (29.3) 5 (6.4)
Intermediate 73 (52.9) 10 (7.3) 73 (55.3) 57 (46.3) 17 (21.8)
Low 8 (5.8) 2 (1.5) 13 (9.8) 30 (24.4) 56 (71.8)
Tot answer 138 (73.0) 137 (72.5) 132 (69.8) 123 (65.1) 78 (41.3)
No answer 51 (27.0) 52 (27.5) 57 (30.2) 66 (34.9) 111 (58.7)
Percentages are given in brackets
DWI: Diffusion Weighted Imaging; MRS: magnetic resonance spectroscopy
Table 4 Details on reporting habits
% (positive /total answers)
Reporting viewer
PACS 40.4 (57/141)
Scanner software 2.8 (4/141)
MRI workstation 38.3 (54/141)
Multiple systems 18.4 (26/141)
Reporting setting
Standardised 64.5 (91/141)
Flexible 35.5 (50/141)
Report style
Free text 17.4 (24/138)
Structured reporting 8.7 (12/138)
Structured reporting and free text 73.9 (102/138)
Diagnostic criteria
BI-RADS only 33.6 (47/140)
BI-RADS and additional features 53.6 (75/140)
Non BI-RADS 12.8 (18/140)
Rating systems
BI-RADS only 46.4 (65/140)
Other scoring systems 4.3 (6/140)
Empirical only 12.1 (17/140)
Combination of the above 37.1 (52/140)
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the latter, the use of BI-RADS [13] was as widespread as
expected. This must be considered a big advantage in the
community of breast specialists: the use of well-defined de-
scriptors and diagnostic categories provides a common lan-
guage, especially important for a diagnostic tool like breast
MRI that is technically complex, with interpretation based on
a variety of diagnostic criteria.
Additional techniques
Additional MRI techniques such as DWI and MRS have been
investigated for more than a decade. While there is common
acceptance that MRS is still impractical in the clinical setting
[26, 27], several studies demonstrate that evaluationwith DWI
can improve breast MRI accuracy, particularly specificity [24,
25, 28]. Despite that, only slightlymore than half of the survey
participants regularly applied DWI, and the technique was
considered not very important for image interpretation by
one-quarter of the survey participants. This may change in
the future, as reflected by the body of evidence given above,
and the fact that radiologists with less than 10 years of expe-
rience in breast MRI considered DWI (and, to some degree,
MRS as well) more helpful for lesion diagnosis, compared to
their more experienced colleagues.
Of note, MRI protocols may in the future be tailored to
specific clinical indications: while a comprehensive diagnostic
scan e.g. in the preoperative setting may profit from a sophis-
ticated multiparametric protocol [29, 30], a screening
Table 5 Answers on technical details of the examination
Question
1/1.5T 1.5T 3T 1.5/3T Total answers No answer
Type and operating magnet field strength 1
0.6%
94
57.3%
37
22.6%
32
19.5%
164 25
Is there a dedicated breast coil (best equipment)
in your institution?
Yes No Don’t know Total answers No answer
158
97%
4
2%
2
1%
164 25
If yes, how many channels? <7 ≥7 Don’t know Total answers No answer
16
18%
69
79%
3
3%
88 101
Do you use an injector for contrast medium Yes No Don’t know Total answers No answer
135
82%
18
11%
11
7%
164 25
Flow rate? <2 ml/s - manual ≥2 ml/s Don’t know Total answers No answer
7
11%
45
74%
9
15%
61 128
Contrast Medium dose? 0.1—0.15 mmol/kg 0.2 mmol/kg Don’t know Total answers No answer
97
68%
29
20%
16
11%
142 47
Which kind of dynamic sequence do you use? 2D 3D Both Total answers No answer
30
21%
104
73%
8
6%
142 47
Do you prefer fat saturation in dynamic imaging? Yes No Don’t know Total answers No answer
109
77%
24
17%
8
6%
141 48
If you are using fat saturation, which kind
do you prefer?
Spectral fat-sat SPAIR Other Total answers No answer
41
42%
42
43%
15
15%
98 91
Which T2-weighted sequence do you use? TSE w/o fat-sat TSE with fat-sat Both Total answers No answer
46
29%
81
50%
34
21%
164 28
Orientation of T2w imaging Axial Sagittal Coronal More than one Total answers No answer
126
80%
1
1%
3
2%
27
17%
157 32
Do you use Diffusion Weighted Imaging? Yes Selected cases No Total answers No answer
85
60%
21
15%
36
25%
142 47
Do you use MR spectroscopy? Yes Selected cases No Total answers No answer
3
2%
19
14%
116
84%
138 51
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examination may rather be as short as possible to enable high
patient throughput [31–33].
Regarding examination protocols, the vast majority of the
centres follow current state-of-the-art recommendations [2, 3,
34]. Despite the traditional belief that non-fat-saturated im-
ages are more commonly used in European countries com-
pared to the USA, we found that fat-saturated, T1-weighted
sequences are most commonly used to acquire dynamic
contrast-enhanced images. Fat suppression can simplify the
evaluation if significant movement artefacts are present [34].
Breast interventions
The necessity to perform MRI-guided interventions for le-
sions visible only on MR images is stressed by a cancer rate
around 20% in these lesions [35–40]. Although centres with a
sufficient caseload are recommended to provide MRI-guided
biopsies, our survey shows a different reality. Most survey
participants did not offer MRI-guided breast interventions.
Considering these results, the importance of targeted (or
Bsecond-look^) ultrasound must be emphasised. Targeted ul-
trasound is a widely available approach to avoid further MRI
interventions and follow-ups in a substantial percentage of
patients [38]. However, for lesions not identifiable by ultra-
sound, MR-guided interventions are a necessity. Without
these, MRI findings cannot be translated into clinical strate-
gies [41].
Limitations
This survey specifically targeted EUSOBI members and is,
therefore, potentially biased towards radiologists with a spe-
cial interest in breast imaging. As is typical for surveys, the
response rate was below 50% [14, 15]. Participants were not
evenly distributed among European countries, a fact that is
also attributable to the distribution of members within the
society, with the best-represented countries being Italy, the
Netherlands, and United Kingdom, while other countries such
as Germany and France are less represented within the
EUSOBI. Furthermore, national differences in the amount of
screening and assessment examinations performed in outpa-
tient settings and private hospitals as compared to academic
centres may further contribute to these heterogeneities and
thus explain the imbalance of responders per country. The
grouping into different regions is due to clustered survey data.
While the association of some countries with specific regions
does not reflect the UN definition of European regions (http://
unstats.un.org/unsd/methods/m49/m49regin.htm#europe),
they reflect a similarity of clinical practice in breast MR
application. Our survey required already more than 10-15 mi-
nutes. To achieve an acceptable compliance, it was not possi-
ble to add further questions regarding several other issues
(breast MRI acceptance between clinicians, reasons for
differences between countries and institutions, use of alterna-
tive methods for MR-guided interventions). A further survey
could be of interest to analyse the points that were only raised
within the current study.
Conclusions
Our survey is the first to reveal data about the actual use of
MRI of the breast by the members of the EUSOBI. While
substantial differences regarding several subtopics between
countries of residence were noted, the following can be
concluded:
1. Despite on-going controversial discussions, MRI is used
for breast cancer staging and problem-solving by most
responders, regardless of the setting.
2. Standardised diagnostic criteria and documentation
(mainly BI-RADS) are generally adopted.
3. Breast radiologists with ≤10 years of experience preferred
additional techniques, such as DWI, hinting at a generation-
rather than an evidence-based influence on the use of these
techniques.
4. There is no BEuropean^ breast MRI technique, as proto-
cols vary among users. The majority of responders apply
fat-saturated protocols both in T1w and T2w imaging.
5. MRI-guided breast interventions are not widely available,
which must be considered as a serious weakness for a
more intense distribution of this technique.
The data presented allow for a better perception of the
current use of breast MRI within the EUSOBI and in
Europe, and highlight the need to improve the availability of
MRI-guided interventions in European countries
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